Latest news

• CiMaas filed patent application on feeder cell preparation in support of its NK cell therapy program August 23, 2023
• CiMaas has created a master cell and working cell bank of its feeder cell line to expand NK cells with maximum proliferation July 1, 2023
• CiMaas receives a LIOF grant to optimize feeder cells preparation facilitating expansion of Natural Killer cells  April 17, 2023
• CiMaas receives exclusive option for the use of high affinity antibody structures in immune cells, including CAR-NK and CAR-T cells March 30, 2023
• Dean Lee joins scientific advisory board of CiMaas December 24, 2022